{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:22:25Z","timestamp":1794576145217,"version":"4.9.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004590","name":"Helse Midt-Norge","doi-asserted-by":"publisher","award":["2020\/39645"],"award-info":[{"award-number":["2020\/39645"]}],"id":[{"id":"10.13039\/501100004590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["332850"],"award-info":[{"award-number":["332850"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.curtheres.2026.100846","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:33:04Z","timestamp":1790177584000},"page":"100846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Glucagon enhances subcutaneous insulin absorption: Pilot experiments in pigs"],"prefix":"10.1016","volume":"105","author":[{"given":"Misbah","family":"Riaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilze","family":"Dirnena-Fusini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sverre Christian","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven Magnus","family":"Carlsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9277","key":"10.1016\/j.curtheres.2026.100846_bib0001","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(01)05415-0","article-title":"Type 1 diabetes: new perspectives on disease pathogenesis and treatment","volume":"358","author":"Atkinson","year":"2001","journal-title":"Lancet"},{"issue":"9911","key":"10.1016\/j.curtheres.2026.100846_bib0002","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.curtheres.2026.100846_bib0003","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1464-5491.1993.tb00060.x","article-title":"Persisting mortality in diabetic ketoacidosis","volume":"10","author":"Basu","year":"1993","journal-title":"Diabet Med"},{"issue":"12","key":"10.1016\/j.curtheres.2026.100846_bib0004","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1089\/dia.2021.0164","article-title":"Missed and mistimed insulin doses in people with diabetes: a systematic literature review","volume":"23","author":"Robinson","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.curtheres.2026.100846_bib0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40262-019-00834-5","article-title":"Fast-acting insulin aspart: a review of its pharmacokinetic and pharmacodynamic properties and the clinical consequences","volume":"59","author":"Haahr","year":"2020","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"10.1016\/j.curtheres.2026.100846_bib0006","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.2337\/dc18-1249","article-title":"First look at control-IQ: a new-generation automated insulin delivery system","volume":"41","author":"Brown","year":"2018","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.curtheres.2026.100846_bib0007","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2337\/dc20-2106","article-title":"Fully closed loop glucose control with a bihormonal artificial pancreas in adults with type 1 diabetes: an outpatient, randomized, crossover trial","volume":"44","author":"Blauw","year":"2021","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.curtheres.2026.100846_bib0008","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1016\/S2589-7500(24)00002-5","article-title":"Bihormonal fully closed-loop system for the treatment of type 1 diabetes: a real-world multicentre, prospective, single-arm trial in the Netherlands","volume":"6","author":"van Bon","year":"2024","journal-title":"Lancet Digit Health"},{"issue":"3","key":"10.1016\/j.curtheres.2026.100846_bib0009","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/dia.2013.0166","article-title":"Feasibility of a portable bihormonal closed-loop system to control glucose excursions at home under free-living conditions for 48 hours","volume":"16","author":"van Bon","year":"2014","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"10.1016\/j.curtheres.2026.100846_bib0010","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamasurg.2022.3702","article-title":"Bihormonal artificial pancreas with closed-loop glucose control vs current diabetes care after total pancreatectomy: a randomized clinical trial","volume":"157","author":"van Veldhuisen","year":"2022","journal-title":"Jama Surg"},{"key":"10.1016\/j.curtheres.2026.100846_bib0011","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s13300-017-0263-6","article-title":"A review of the current challenges associated with the development of an artificial pancreas by a double subcutaneous approach","volume":"8","author":"Christiansen","year":"2017","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.curtheres.2026.100846_bib0012","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1205121","article-title":"Factors affecting the absorption of subcutaneously administered insulin: effect on variability","volume":"2018","author":"Gradel","year":"2018","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.curtheres.2026.100846_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175045","article-title":"The effect of glucagon on local subcutaneous blood flow in non-diabetic volunteers; a proof-of-concept study","volume":"926","author":"\u00c5m","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.curtheres.2026.100846_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.986858","article-title":"Vasodilatory effects of glucagon: a possible new approach to enhanced subcutaneous insulin absorption in artificial pancreas devices","volume":"10","author":"Teigen","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"issue":"3","key":"10.1016\/j.curtheres.2026.100846_bib0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40618-023-02193-2","article-title":"The artificial pancreas: two alternative approaches to achieve a fully closed-loop system with optimal glucose control","volume":"47","author":"\u00c5m","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.curtheres.2026.100846_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.curtheres.2024.100736","article-title":"Effects of low-dose glucagon on subcutaneous insulin absorption in pigs","volume":"100","author":"Teigen","year":"2024","journal-title":"Curr Ther Res Clin Exp"},{"issue":"10","key":"10.1016\/j.curtheres.2026.100846_bib0017","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1111\/dom.14094","article-title":"Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: a phase 1 randomized, crossover study","volume":"22","author":"Heise","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"6229","key":"10.1016\/j.curtheres.2026.100846_bib0018","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/bmj.280.6229.1411","article-title":"Sauna-induced acceleration in insulin absorption from subcutaneous injection site","volume":"280","author":"Koivisto","year":"1980","journal-title":"Br Med J"},{"issue":"11","key":"10.1016\/j.curtheres.2026.100846_bib0019","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s00125-005-1930-0","article-title":"Oestrogens and insulin secretion","volume":"48","author":"Godsland","year":"2005","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.curtheres.2026.100846_bib0020","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98569","article-title":"17-beta estradiol regulates proglucagon-derived peptide secretion in mouse and human alpha- and L cells","volume":"3","author":"Handgraaf","year":"2018","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.curtheres.2026.100846_bib0021","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1210\/endo-92-3-762","article-title":"Sex steroid influence on hepatic gluconeogenesis and glycogen formation","volume":"92","author":"Matute","year":"1973","journal-title":"Endocrinology"},{"issue":"16","key":"10.1016\/j.curtheres.2026.100846_bib0022","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15009","article-title":"Mini-review: glucagon responses in type 1 diabetes\u2013a matter of complexity","volume":"9","author":"Bisgaard Bengtsen","year":"2021","journal-title":"Physiol Rep"},{"issue":"6","key":"10.1016\/j.curtheres.2026.100846_bib0023","doi-asserted-by":"crossref","first-page":"R267","DOI":"10.1530\/EJE-18-0197","article-title":"EJE PRIZE 2018: a gut feeling about glucagon","volume":"178","author":"Knop","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.curtheres.2026.100846_bib0024","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/jdi.13486","article-title":"Impact of glucagon response on early postprandial glucose excursions irrespective of residual \u03b2-cell function in type 1 diabetes: a cross-sectional study using a mixed meal tolerance test","volume":"12","author":"Ito","year":"2021","journal-title":"J Diabetes Invest"},{"key":"10.1016\/j.curtheres.2026.100846_bib0025","series-title":"Endotext [Internet]","article-title":"Glucagon Physiology","author":"Rix","year":"2000"},{"issue":"4","key":"10.1016\/j.curtheres.2026.100846_bib0026","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s13318-021-00692-2","article-title":"Pharmacokinetics of intraperitoneally delivered glucagon in pigs: a hypothesis of first pass metabolism","volume":"46","author":"Teigen","year":"2021","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"6","key":"10.1016\/j.curtheres.2026.100846_bib0027","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/bcpt.13731","article-title":"Pharmacokinetics of glucagon after intravenous, intraperitoneal and subcutaneous administration in a pig model","volume":"130","author":"Teigen","year":"2022","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"12","key":"10.1016\/j.curtheres.2026.100846_bib0028","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1177\/0271678X18789273","article-title":"Effects of anesthesia on cerebral blood flow, metabolism, and neuroprotection","volume":"38","author":"Slupe","year":"2018","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X26000275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X26000275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:23:16Z","timestamp":1794572596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X26000275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":28,"alternative-id":["S0011393X26000275"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2026.100846","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon enhances subcutaneous insulin absorption: Pilot experiments in pigs","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2026.100846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100846"}}